Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Acreal

Explore full profile

Advanced digital scanning and software for dentistry

Seoul, South KoreaFounded 2021Health Tech & Medtech
Valuation $25–50M Last recorded · 2025
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Acreal and the history behind them.

About Acreal

Acreal is a digital healthcare company focused on transforming the dental industry with its integrated suite of technology products. The company develops and provides an intraoral scanner, CAD software, and a digital cloud-based platform designed to streamline dental workflows. Its core product, the arcscan, is a lightweight and slim intraoral 3D scanner engineered for efficiency and patient comfort. It features high-speed scanning and vivid color reconstruction, allowing for a more relaxed scanning procedure without a strict path.

The arcscan scanner is complemented by arcgrid, a cloud-based dental platform that facilitates seamless data sharing and communication between dental clinics and laboratories. This platform is designed to optimize dental restoration workflows and supports data-driven diagnostics for treatment planning. While Acreal provides its own software ecosystem, its hardware maintains an open architecture; scan data can be exported in STL, PLY, and OBJ formats, ensuring compatibility with third-party CAD software. The company's business model appears to be centered on the sale of its hardware and accompanying software platform to dental professionals, aiming to improve the efficiency of creating digital impressions for restorations, implants, and orthodontics.

Acreal's team consists of software engineers with backgrounds in 3D graphics, AI, smartphone design, mobility, and medical device manufacturing. The company has secured funding from venture capital firms that specialize in AI, robotics, and digital healthcare.

Source: Dealroom company data

At a glance

Founded
2021
Headquarters
Seoul, South Korea
Sector
Health Tech & Medtech

Investors

5 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed5 investors entered at this stage

  • DSC Investment
  • Schmidt
  • InterVest
  • Quantum Ventures Korea
  • SDB Investment
Team profiled 2 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇰🇷 South Korea88.9%
🇺🇸 United States11.1%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Acreal on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Acreal on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.